A central venous catheter (“CVC”) is formed of a material having a relatively low durometer, which contributes to the CVC having a lack of column strength. Due to the lack of column strength, CVCs are commonly introduced into patients and advanced through their vasculatures by way of the Seldinger technique. The Seldinger technique utilizes a number of steps and medical devices (e.g., a needle, a scalpel, a guidewire, an introducer sheath, a dilator, a CVC, etc.). While the Seldinger technique is effective, the number of steps is time consuming, handling the number of medical devices is awkward, and both of the foregoing can lead to patient trauma. In addition, there is a relatively high potential for touch contamination due to the number of medical devices that need to be interchanged during the number of steps of the Seldinger technique. As such, there is a need to reduce the number of steps and medical devices involved in introducing a catheter such as a CVC into a patient and advancing the catheter through a vasculature thereof.
Disclosed herein are rapidly insertable central catheters (“RICCs”) including catheter assemblies and methods thereof that address the foregoing.
Disclosed herein is a RICC assembly. The RICC assembly includes, in some embodiments, a RICC, an introducer, and a coupling system configured to couple the RICC and the introducer together. The RICC includes a catheter tube, a catheter hub, and one or more extension legs. The catheter tube includes a first section formed of a first material having a first durometer and a second section formed of a second material having a second durometer less than the first durometer. The catheter tube includes a side aperture through a side of the catheter tube in a distal-end portion thereof but proximal of the first section of the catheter tube. The side aperture opens into an introducing lumen of the catheter tube that extends from at least the side aperture to a distal end of the RICC. The catheter hub is coupled to a proximal-end portion of the catheter tube. Each extension leg of the one-or-more extension legs is coupled to the catheter hub by a distal-end portion thereof. The introducer includes an introducer needle having a cannula extending through the distal end of the RICC when the RICC assembly is in at least a ready-to-deploy state of the RICC assembly. The coupling system includes a distal coupler slidably attached to the catheter tube proximal of the side aperture.
In some embodiments, the cannula further extends through a longitudinal through hole of the distal coupler, through the side aperture of the catheter tube, and along the introducing lumen of the catheter tube before exiting through the distal end of the RICC when the RICC assembly is in at least the ready-to-deploy state thereof
In some embodiments, the distal coupler includes a tab configured to allow a clinician to single handedly advance the RICC off the cannula with a single finger of a hand while holding the introducer between a thumb and another finger or fingers of the hand.
In some embodiments, the introducer further includes a syringe and an access guidewire. The syringe has a syringe tip coupled to a needle hub of the introducer needle. The access guidewire is disposed in an access-guidewire lumen formed of at least a plunger lumen of a plunger of the syringe and a needle lumen of the introducer needle. The access guidewire has a length sufficient for extension of the access guidewire through the distal end of the RICC.
In some embodiments, the plunger includes a sealing mechanism in a proximal-end portion of the plunger for sealing off the access-guidewire lumen. The sealing mechanism is configured to prevent blood from discharging through a proximal end of the plunger during a venipuncture or while withdrawing the access guidewire from a blood-vessel lumen of a patient.
In some embodiments, the access guidewire is captively disposed in the introducer by a stop about a proximal-end portion of the access guidewire and a closed end of an access-guidewire sterile barrier of a fixed length coupled to the proximal end of the plunger. The stop provides a distal limit to advancing the access guidewire. The closed end of the access-guidewire sterile barrier around the access guidewire provides a proximal limit to withdrawing the access guidewire.
In some embodiments, the introducer further includes a fluid-pressure indicator extending from a side arm of the needle hub. The fluid-pressure indicator is fluidly coupled to the needle lumen of the introducer needle by way of a side-arm lumen of the side arm for observing blood flashback.
In some embodiments, the coupling system further includes a proximal coupler slidably attached to the catheter hub and removably attached to the syringe in at least the ready-to-deploy state of the RICC assembly. The coupling system is configured to allow the RICC to slide relative to the introducer.
In some embodiments, the proximal coupler includes a catheter-hub clip from which the RICC is configured to suspend by the catheter hub in at least the ready-to-deploy state of the RICC assembly. The RICC is configured to suspend from the catheter-hub clip by the one-or-more extension legs when the proximal coupler is advanced thereover in an operating state of the RICC assembly.
In some embodiments, the proximal coupler includes a syringe clip. The introducer is configured to rest in the syringe clip by a distal-end portion of a barrel of the syringe in at least the ready-to-deploy state of the RICC assembly.
In some embodiments, the RICC further includes a collapsible catheter-tube sterile barrier over the catheter tube between the catheter hub and the distal coupler to which distal coupler the catheter-tube sterile barrier is coupled. The catheter-tube sterile barrier is configured to split apart when a sterile-barrier tab of the catheter-tube sterile barrier is removed from the catheter-hub clip and the catheter-tube sterile barrier is pulled away from the catheter tube by the sterile-barrier tab.
In some embodiments, the catheter-tube sterile barrier has sufficient tensile strength to pull the distal coupler off the catheter tube without breaking when the catheter-tube sterile barrier splits down to the distal coupler while being pulled away from the catheter tube.
In some embodiments, the RICC includes a set of three lumens including a distal lumen, a medial lumen, and a proximal lumen. The set of three lumens is formed of fluidly connected portions of three catheter-tube lumens, three hub lumens, and three extension-leg lumens. The introducing lumen of the catheter tube is coincident with a distal-end portion of the distal lumen.
In some embodiments, the distal lumen has a distal-lumen aperture in a distal end of the RICC, the medial lumen has a medial-lumen aperture in the side of the catheter tube distal of the side aperture, and the proximal lumen has a proximal-lumen aperture in the side of the catheter tube distal of the side aperture but proximal of the medial-lumen aperture.
In some embodiments, the RICC further includes a maneuver guidewire disposed in the distal lumen. The maneuver guidewire has a length sufficient for extension of the maneuver guidewire to a lower ⅓ of a superior vena cava of a heart. The maneuver guidewire is captively disposed in the RICC by a stop about a proximal-end portion of the maneuver guidewire and a closed end of a maneuver-guidewire sterile barrier of a fixed length coupled to a Luer connector. The stop provides a distal limit to advancing the maneuver guidewire. The closed end of the maneuver-guidewire sterile barrier around the maneuver guidewire provides a proximal limit to withdrawing the maneuver guidewire.
Also disclosed herein is a method for inserting a RICC into a blood-vessel lumen of a patient. The method includes, in some embodiments, a RICC assembly-obtaining step, a needle tract-establishing step, a first RICC-advancing step, and an introducer-withdrawing step. The RICC assembly-obtaining step includes obtaining a RICC assembly. The RICC assembly includes the RICC, an introducer, and a coupling system that couples the RICC and the introducer together. The introducer includes a syringe coupled to an introducer needle. The coupling system includes a distal coupler that couples the RICC and the introducer together by distal-end portions thereof in at least a ready-to-deploy state of the RICC assembly. The needle tract-establishing step includes establishing a needle tract from an area of skin to the blood-vessel lumen of the patient with a cannula of the introducer needle while holding a distal-end portion of a barrel of the syringe. The cannula extends through a longitudinal through hole of the distal coupler, through a side aperture in a distal-end portion of a catheter tube of the RICC, along an introducing lumen of the catheter tube, and out a distal end of the RICC for establishing the needle tract. The first RICC-advancing step includes advancing a distal-end portion of the catheter tube into the blood-vessel lumen over the cannula. The introducer-withdrawing step includes withdrawing the cannula from the introducing lumen by way of the side aperture of the catheter tube.
In some embodiments, the method further includes a blood-aspirating step. The blood-aspirating step includes aspirating blood with the syringe before withdrawing the cannula from the introducing lumen. The blood-aspirating step confirms the cannula is disposed in the blood-vessel lumen of the patient.
In some embodiments, the needle tract-establishing step includes ensuring blood flashes back into a needle hub of the introducer needle, a side arm of the needle hub, or a fluid-pressure indicator extending from the side arm of the needle hub.
In some embodiments, the needle tract-establishing step includes holding the barrel by a syringe clip around the distal-end portion of the barrel. The syringe clip is part of a proximal coupler of the coupling system.
In some embodiments, the first RICC-advancing step includes advancing the catheter tube into the blood-vessel lumen with a single finger of a hand while holding the barrel of the syringe by the syringe clip between a thumb and another finger or fingers of the hand. The distal coupler includes a tab configured for advancing the catheter tube into the blood-vessel lumen with the single finger.
In some embodiments, the first RICC-advancing step includes advancing a catheter hub of the RICC from a catheter-hub clip of the proximal coupler. After advancing the catheter hub from the catheter-hub clip, one or more extension legs of the RICC are advanced within the catheter-hub clip. The RICC is configured to suspend from the coupling system until at least withdrawing the cannula from both the introducing lumen and the longitudinal through hole of the distal coupler.
In some embodiments, the method further includes an access guidewire-advancing step. The access guidewire-advancing step includes advancing an access guidewire disposed in an access-guidewire lumen formed of at least a plunger lumen of a plunger of the syringe and a needle lumen of the introducer needle into the blood-vessel lumen beyond a distal end of the cannula before the first RICC-advancing step.
In some embodiments, the method further includes a maneuver guidewire-advancing step. The maneuver guidewire-advancing step includes advancing a maneuver guidewire into the blood-vessel lumen by way of a distal lumen having a distal-lumen aperture in the distal end of the RICC. The introducing lumen of the catheter tube is coincident with a distal-end portion of the distal lumen, thereby mandating withdrawing the cannula from the introducing lumen before the maneuver guidewire-advancing step.
In some embodiments, the method further includes a second RICC-advancing step. The second RICC-advancing step includes advancing the distal-end portion of the catheter tube farther into the blood-vessel lumen over the maneuver guidewire. The second RICC-advancing step includes concomitantly sliding the distal coupler proximally toward a proximal-end portion of the catheter tube to uncover the catheter tube. The catheter tube is covered by a collapsible sterile barrier between the proximal-end portion of the catheter tube and the distal coupler in at least the ready-to-deploy state of the RICC assembly.
In some embodiments, the method further includes a sterile barrier-removing step. The sterile barrier-removing step includes removing the sterile barrier and the distal coupler from the RICC by pulling a sterile-barrier tab of the sterile barrier opposite the distal coupler away from the catheter tube to split the sterile barrier apart, then pulling the distal coupler from the catheter tube by the sterile barrier to which the distal coupler is slidably attached.
In some embodiments, the catheter tube includes a first section formed of a first material having a first durometer and a second section proximal of the first section formed of a second material having a second durometer less than the first durometer. The first section of the catheter tube is configured with a column strength for advancing the catheter tube into the blood-vessel lumen over the access guidewire or the maneuver guidewire.
These and other features of the concepts provided herein will become more apparent to those of skill in the art in view of the accompanying drawings and following description, which describe particular embodiments of such concepts in greater detail.
Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.
Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
With respect to “proximal,” a “proximal portion” or a “proximal-end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near a clinician when the catheter is used on a patient. Likewise, a “proximal length” of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient. A “proximal end” of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient. The proximal portion, the proximal-end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal-end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal-end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.
With respect to “distal,” a “distal portion” or a “distal-end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near or in a patient when the catheter is used on the patient. Likewise, a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient. A “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient. The distal portion, the distal-end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal-end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal-end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.
As set forth above, there is a need to reduce the number of steps and medical devices involved in introducing a catheter such as a CVC into a patient and advancing the catheter through a vasculature thereof.
Disclosed herein are rapidly insertable central catheters (“RICCs”) including catheter assemblies and methods thereof that address the foregoing. However, it should be understood the RICCs are but one type of catheter in which the concepts provided herein can be embodied or otherwise incorporated. Indeed, peripherally inserted central catheters (“PICCs”), dialysis catheters, or the like can also embody or otherwise incorporate the concepts provided herein for the RICCs, as well as catheter assemblies and methods thereof.
RICC Assemblies
As shown, the RICC assembly 100 includes, in some embodiments, the RICC 102, the introducer 104, and the coupling system 106 configured to couple the RICC 102 and the introducer 104 together. The RICC 102, the introducer 104, and the coupling system 106 are described, in turn, in sections set forth below; however, some crossover between the sections for the RICC 102, the introducer 104, and the coupling system 106 exist in view of the interrelatedness of the RICC 102, the introducer 104, and the coupling system 106 in the RICC assembly 100.
The RICC 102 includes the catheter tube 108, a catheter hub 110, and one or more extension legs 112.
The catheter tube 108 includes two or more sections including a tip 114 in a distal-end portion of the catheter tube 108, one or more catheter-tube lumens, and a side aperture 116 through a side of the catheter tube 108 in the distal-end portion of the catheter tube 108.
The two or more sections of the catheter tube 108 can be a main body of the catheter tube 108 and the tip 114, which can be formed as a single extruded piece of a single material or a single coextruded piece of two similar materials. Alternatively, the main body of the catheter tube 108 and the tip 114 can be formed as two different extruded pieces of two similar materials and subsequently coupled. However,
The first section 118 of the catheter tube 108 can be formed of a first material (e.g., a polymeric material such as polytetrafluoroethylene, polypropylene, or polyurethane) having a first durometer, while the second section 120 of the catheter tube 108 can be formed of a second material (e.g., a polymeric material such as polyvinyl chloride, polyethylene, polyurethane, or silicone) having a second durometer less than the first durometer. For example, each section of the first section 118 and the second section 120 of the catheter tube 108 can be made from a different polyurethane having a different durometer. Indeed, polyurethane is advantageous in that polyurethane sections of the catheter tube 108 can be relatively rigid at room-temperature but become more flexible in vivo at body temperature, which reduces irritation to vessel walls and phlebitis. Polyurethane is also advantageous in that can be less thrombogenic than some other polymers.
The catheter tube 108 having at least the first section 118 of the first polymeric material and the second section 120 of the second polymeric material has a column strength sufficient to prevent buckling of the catheter tube 108 when the catheter tube 108 is inserted into an insertion site and advanced through a vasculature of a patient. The column strength of the catheter tube 108 is notable in that it makes it possible to rapidly insert the catheter tube 108 into the insertion site and advance the catheter tube 108 through the vasculature of the patient without using the Seldinger technique.
It should be understood the first durometer and the second durometer can be on different scales (e.g., Type A or Type D), so the second durometer of the second polymeric material might not be numerically less than the first durometer of the first polymeric material. That said, the hardness of the second polymeric material can still be less than the hardness of the first polymeric material as the different scales—each of which ranges from 0 to 100—are designed for characterizing different materials in groups of the materials having a like hardness.
Notwithstanding the foregoing, the first section 118 and the second section 120 of the catheter tube 108 can be formed of a same polymeric material or different polymeric materials having substantially equal durometers provided a column strength of the catheter tube 108 is sufficient to prevent buckling of the catheter tube 108 when inserted into an insertion site and advanced through a vasculature of a patient.
The one-or-more catheter-tube lumens can extend through an entirety of the catheter tube 108; however, only one catheter-tube lumen typically extends from a proximal end of the catheter tube 108 to a distal end of the catheter tube 108 in a multiluminal RICC (e.g., a diluminal RICC, a triluminal RICC, a tetraluminal RICC, a pentaluminal RICC, a hexaluminal RICC, etc.). Indeed, the tip 114 typically includes a single lumen therethrough. Optionally, the single lumen through the tip 114 can be referred to as a “tip lumen,” particularly in reference to the first section 118 of the catheter tube 108, which is formed separately from a remainder of the catheter tube 108 and coupled thereto.
Again, the side aperture 116 is through a side of the catheter tube 108 in the distal-end portion of the catheter tube 108; however, the side aperture 116 is proximal of the first section 118 of the catheter tube 108. The side aperture 116 opens into an introducing lumen 124 of the one-or-more catheter-tube lumens. The introducing lumen 124 extends from at least the side aperture 116 in the second section 120 of the catheter tube 108, through the first section 118 of the catheter tube 108 distal thereof, and to a distal end of the RICC 102 (e.g., the distal end of the catheter tube 108 or a distal end of the tip 114). The introducing lumen 124 is coincident with a distal-end portion of the one catheter-tube lumen set forth above that typically extends from the proximal end of the catheter tube 108 to the distal end of the catheter tube 108, particularly the distal-end portion of the foregoing catheter-tube lumen distal of the side aperture 116.
The catheter hub 110 is coupled to a proximal-end portion of the catheter tube 108. The catheter hub 110 includes one or more catheter-hub lumens corresponding in number to the one-or-more catheter-tube lumens. The one-or-more catheter-hub lumens extend through an entirety of the catheter hub 110 from a proximal end of the catheter hub 110 to a distal end of the catheter hub 110.
Each extension leg of the one-or-more extension legs 112 is coupled to the catheter hub 110 by a distal-end portion thereof. The one-or-more extension legs 112 respectively include one or more extension-leg lumens, which, in turn, correspond in number to the one-or-more catheter-tube lumens. Each extension-leg lumen of the one-or-more extension-leg lumens extends through an entirety of the extension leg from a proximal end of the extension leg to a distal end of the extension leg.
Each extension leg of the one-or-more extension legs 112 typically includes a Luer connector coupled to the extension leg, through which Luer connector the extension leg and the extension-leg lumen thereof can be connected to another medical device.
While the RICC 102 can be a monoluminal or multiluminal RICC (e.g., a diluminal RICC, a triluminal RICC, a tetraluminal RICC, a pentaluminal RICC, a hexaluminal RICC, etc.), the RICC 102 shown in
The RICC 102 can further include a maneuver guidewire 138. While not shown, the maneuver guidewire 138 can include an atraumatic tip (e.g., a coiled or partially coiled tip) and a length sufficient for advancing the maneuver guidewire 138 to the lower ⅓ of the superior vena cava (“SVC”) of the heart. The maneuver guidewire 138 can be captively disposed in the RICC 102 in at least a ready-to-deploy state of the RICC assembly 100. For example, the maneuver guidewire 138 can be disposed in the distal lumen 126 of the RICC 102 with a proximal-end portion or a medial portion of the maneuver guidewire 138 disposed in the extension leg-lumen portion of the distal lumen 126, the medial portion or a distal-end portion of the maneuver guidewire 138 disposed in the hub-lumen portion of the distal lumen 126, and the distal-end portion of the maneuver guidewire 138 disposed in the catheter tube-lumen portion of the distal lumen 126, which is formed of the one catheter-tube lumen set forth above that typically extends from the proximal end of the catheter tube 108 to the distal end of the catheter tube 108. However, the distal-end portion of the foregoing catheter-tube lumen distal of the side aperture 116 is coincident with the introducing lumen 124, which, as set forth below, is occupied by the introducer needle 143 in at least the ready-to-deploy state of the RICC assembly 100. Due to the presence of the introducer needle 143 in the introducing lumen 124, a distal end of the maneuver guidewire 138 is just short of the side aperture 116 in at least the ready-to-deploy state of the RICC assembly 100.
The maneuver guidewire 138 includes a stop 140 (e.g., a hub, a ball, a slug, etc.) about a proximal-end portion of the maneuver guidewire 138 forming a stop end (e.g., a hub end, a ball end, a slug end, etc.) of the maneuver guidewire 138. The stop end of the maneuver guidewire 138 is larger than a proximal-end opening of the distal lumen 126 or the extension leg-lumen portion thereof, thereby providing a distal limit for advancing the maneuver guidewire 138 into the RICC 102. In addition, the maneuver guidewire 138 is disposed in a fixed-length sterile barrier 142 (e.g., a longitudinal bag) including a closed or sealed proximal end and an otherwise open distal end removably coupled (e.g., removably adhered) to a proximal end of the Luer connector of the extension leg for manual removal of both the sterile barrier 142 and the maneuver guidewire 138 when needed. A combination of the fixed length of the sterile barrier 142, the closed or sealed proximal end of the sterile barrier 142, and the distal end of the sterile barrier 142 coupled to the Luer connector provides a limited tract within which the maneuver guidewire 138 can proximally move, thereby providing a proximal limit for withdrawing the maneuver guidewire 138 from the RICC 102. The proximal limit keeps the atraumatic tip of the maneuver guidewire 138 in the distal lumen 126 where, in at least the embodiment of the atraumatic tip having the coiled or partially coiled tip, the atraumatic tip remains in a straightened or uncoiled state. This is advantageous for it can be particularly difficult to reinsert such a guidewire in a lumen of a medical device such as a catheter. Optionally, the stop end of the maneuver guidewire 138 is coupled (e.g., adhered) to the proximal end of the sterile barrier 142 to maintain the stop end of the maneuver guidewire 138 in the proximal end of the sterile barrier 142, thereby reducing a mismatch between a length of the proximal-end portion of the maneuver guidewire 138 extending beyond the proximal end of the RICC 102 (e.g., a proximal end of the Luer connector) and an unpleated length of the sterile barrier 142. Reducing the mismatch between the foregoing lengths reduces a likelihood of losing the stop end of the maneuver guidewire 138 in a medial portion of the sterile barrier 142, which could require time and effort to rematch that would be better spent focusing on the patient.
In addition to providing the proximal limit for withdrawing the maneuver guidewire from the RICC 102, the sterile barrier 142 is configured to maintain sterility of the maneuver guidewire 138 both before use (e.g., shipping and handling, storage, etc.) of the RICC assembly 100 and during use of the RICC assembly 100. During use of the RICC assembly 100, the sterile barrier 142 is configured to provide a no-touch advancing means for advancing the maneuver guidewire 138 into a blood-vessel lumen of a patient upon establishing a needle tract thereto. Likewise, the sterile barrier 142 is configured to provide a no-touch withdrawing means for withdrawing the maneuver guidewire 138 from the blood-vessel lumen of the patient, for example, after the catheter tube 108 has been advanced over the maneuver guidewire 138.
While not shown, the RICC 102 can further include stiffening stylets such as a stylet in either lumen or both lumens of the medial lumen and the proximal lumen of the triluminal embodiment of the RICC 102 for stiffening the RICC 102, thereby providing additional column strength to prevent buckling of the catheter tube 108 when the catheter tube 108 is inserted into an insertion site and advanced through a vasculature of a patient.
The introducer 104 includes an introducer needle 143, a syringe 144 operably connected to the introducer needle 143, and an access guidewire 146 captively disposed in the introducer 104. The introducer 104 can further include a fluid-pressure indicator 148 operably connected to the introducer needle 143.
The introducer needle 143 includes a needle hub 150 and a cannula 152 extending from the needle hub 150. The needle hub 150 is translucent and preferably colorless for observing blood flashback from a venipuncture with the cannula 152. When the RICC assembly 100 is in at least the ready-to-deploy state as shown in
When present, the fluid-pressure indicator 148 extends from a side arm 156 of the needle hub 150. The fluid-pressure indicator 148 includes a closed end and an open end fluidly coupled to a needle lumen of the introducer needle 143 by way of a side-arm lumen of the side arm 156. The fluid-pressure indicator 148 is configured as a built-in accidental arterial indicator, wherein blood under sufficient pressure (e.g., arterial blood) can enter the fluid-pressure indicator 148 and compress a column of air within the fluid-pressure indicator 148. However, it is also possible to observe the blood flashback from the venipuncture with the cannula 152 in the fluid-pressure indicator 148. That said, the blood flashback form is normally observed in the needle hub 150, the side arm 156 of the needle hub 150, or the syringe 144.
The syringe 144 includes a barrel 158, a plunger 160 disposed in the barrel 158, and a syringe tip 162 extending from a distal end of the barrel 158, which is coupled to the needle hub 150 of the introducer needle 143 when the RICC assembly 100 is in at least the ready-to-deploy thereof. The syringe 144 also includes a syringe portion of an access-guidewire lumen 164 formed of fluidly connected portions of a plunger lumen of the plunger 160, a syringe-tip lumen of the syringe tip 162, and any space within the barrel 158 formed by pulling the plunger 160 partially out of the barrel 158 such as in an operating state of a number of operating states of the RICC assembly 100 (e.g., during the blood-aspirating step of the method set forth below). Another portion of the access-guidewire lumen 164 is the introducer-needle portion of the access-guidewire lumen 164, namely the needle lumen of the introducer needle 143, particularly when the introducer needle 143 is operably connected to the syringe 144 as in most states of the RICC assembly 100.
The plunger 160 includes a sealing mechanism in a proximal-end portion of the plunger 160 for sealing off the access-guidewire lumen 164. The sealing mechanism is configured to seal off the access-guidewire lumen 164 to prevent blood from discharging (e.g., flashing back) through a proximal end of the plunger 160 during a venipuncture or while withdrawing the access guidewire 146 from a blood-vessel lumen of a patient, thereby minimizing or preventing a potential for contaminating an operating field or any clinicians operating within the operating field. Notwithstanding the sealing mechanism, the access guidewire 146 is also disposed in the sterile barrier 170 set forth below, which complements the sealing mechanism in minimizing or preventing the potential for contaminating the operating field or any clinicians operating within the operating field.
As shown in
The access guidewire 146 is captively disposed in the introducer 104 such that at least a portion of the access guidewire 146 is always in a portion (e.g., the plunger-lumen portion, the needle-lumen portion, etc.) of the access-guidewire lumen 164 no matter the state of the RICC assembly 100. For example, when the access guidewire 146 is withdrawn to its proximal limit, a distal-end portion of the access guidewire 146 is disposed in at least a distal-end portion of the plunger lumen. Meanwhile, a proximal-end portion of the access guidewire 146 extends through or beyond a proximal end of the introducer 104 (e.g., a proximal end of the plunger 160). When the RICC assembly 100 is in at least the ready-to-deploy state thereof with a distal end of the access guidewire 146 just short of the cannula tip 154, a medial portion of the access guidewire 146 is disposed between the distal-end portion of the plunger lumen and a proximal-end portion of the needle lumen. And when the access guidewire 146 is advanced to its distal limit in some operating states of the number of operating states of the RICC assembly 100 (e.g., during the access guidewire-advancing step of the method set forth below), the proximal-end portion of the access guidewire 146 is disposed in at least a proximal-end portion of the plunger lumen. Meanwhile, a result of its sufficient length, the distal-end portion of the access guidewire 146 extends through or beyond the distal end of the RICC 102 (e.g., the distal end of the catheter tube 108 or a distal end of the tip 114).
The access guidewire 146 includes a stop 168 (e.g., a hub, a ball, a slug, etc.) about a proximal-end portion of the access guidewire 146 forming a stop end (e.g., a hub end, a ball end, a slug end, etc.) of the access guidewire 146. The stop end of the access guidewire 146 is larger than a proximal-end opening of the access-guidewire lumen 164 or the plunger lumen thereof, thereby providing the foregoing distal limit for advancing the access guidewire 146 into the introducer 104. In addition, the access guidewire 146 is disposed in a fixed-length sterile barrier 170 (e.g., a longitudinal bag) including a closed or sealed proximal end and an otherwise open distal end coupled (e.g., adhered) to the proximal end of the plunger 160. A combination of the fixed length of the sterile barrier 170, the closed or sealed proximal end of the sterile barrier 170, and the distal end of the sterile barrier 170 coupled to the plunger 160 provides a limited tract within which the access guidewire 146 can proximally move, thereby providing the foregoing proximal limit for withdrawing the access guidewire 146 from the introducer 104. Optionally, the stop end of the access guidewire 146 is coupled (e.g., adhered) to the proximal end of the sterile barrier 170 to maintain the stop end of the access guidewire 146 in the proximal end of the sterile barrier 170, thereby reducing a mismatch between a length of the proximal-end portion of the access guidewire 146 extending beyond the proximal end of the introducer 104 (e.g., the proximal end of the plunger 160) and an unpleated length of the sterile barrier 170. Reducing the mismatch between the foregoing lengths reduces a likelihood of losing the stop end of the access guidewire 146 in a medial portion of the sterile barrier 170, which could require time and effort to rematch that would be better spent focusing on the patient.
In addition to providing the proximal limit for withdrawing the access guidewire 146 from the introducer 104, the sterile barrier 170 is configured to maintain sterility of the access guidewire 146 both before use (e.g., shipping and handling, storage, etc.) of the RICC assembly 100 and during use of the RICC assembly 100. During use of the RICC assembly 100, the sterile barrier 170 is configured to provide a no-touch advancing means for advancing the access guidewire 146 into a blood-vessel lumen of a patient upon establishing a needle tract thereto. Likewise, the sterile barrier 170 is configured to provide a no-touch withdrawing means for withdrawing the access guidewire 146 from the blood-vessel lumen of the patient, for example, after the catheter tube 108 has been advanced over the access guidewire 146. Furthermore, as set forth above, the sterile barrier 170 complements the sealing mechanism in minimizing or preventing the potential for blood contaminating the operating field or any clinicians operating within the operating field. Indeed, the sterile barrier 170 is configured as secondary containment for any blood that might discharge (e.g., flash back) through the proximal end of the plunger 160 during a venipuncture or while withdrawing the access guidewire 146 from the blood-vessel lumen of the patient should the sealing mechanism fail in any way to prevent blood from discharging through the proximal end of the plunger 160.
The coupling system 106 includes a distal coupler 172 and a proximal coupler 174 configured to couple the RICC 102 and the introducer 104 together by corresponding proximal-end and distal-end portions thereof in at least the ready-to-deploy state of the RICC assembly 100 while allowing the introducer 104 to slide relative to the RICC 102 (or vice versa).
The distal coupler 172 includes a catheter-tube clip configured to both slidably and removably attach to the catheter tube 108 proximal of the side aperture 116. The distal coupler 172 also includes a longitudinal through hole and a tab 176 in a distal-end portion of the distal coupler 172. The cannula 152 of the introducer needle 143 extends through the longitudinal through hole of the distal coupler 172, through the side aperture 116 of the catheter tube 108, along the introducing lumen 124 of the catheter tube 108, and through the distal end of the RICC 102 when the RICC assembly 100 is in at least the ready-to-deploy state thereof. The tab 176 is configured to allow a clinician to single handedly advance the RICC 102 off the cannula 152 with a single finger of a hand (e.g., with a flick-type motion of the finger) while holding the introducer 104 (e.g., by the distal-end portion of the barrel 158 of the syringe 144 including the syringe clip 180 as set forth below) between a thumb and another finger or fingers of the same hand, thereby providing a no-touch mechanism for advancing the RICC 102, specifically the distal-end portion of the catheter tube 108, over the cannula 152 and into a blood-vessel lumen of a patient.
The proximal coupler 174 includes a catheter-hub clip 178 configured to both slidably and removably attach to the catheter hub 110 or the one-or-more extension legs 112 and a syringe clip 180 configured to removably attach to the syringe 144. The catheter-hub clip 178 is configured for suspending the RICC 102 by the catheter hub 110 in at least the ready-to-deploy state of the RICC assembly 100, thereby keeping the RICC 102 from drooping. The catheter-hub clip 178 is also configured for suspending the RICC 102 by the one-or-more extension legs 112 in some operating states of the number of operating states of the RICC assembly 100 (e.g., during the introducer-removing step of the method set forth below), thereby further keeping the RICC 102 from drooping. The syringe clip 180 is configured to cradle the syringe 144 such that the syringe 144 rests in the syringe clip 180 by a distal-end portion of the barrel 158 in at least the ready-to-deploy state of the RICC assembly 100. Distal placement of the syringe clip 180 about the distal-end portion of the barrel 158 of the syringe 144 encourages holding or handling the introducer 104 in a location that provides better control of a distal-end portion of the RICC 102 including the cannula tip 154 of the cannula 152, for example, when establishing a needle tract from an area of skin to a blood-vessel lumen of a patient. The syringe clip 180 can include a gripping portion (e.g., a pattern of bumps, through holes, etc.) configured to facilitate gripping the syringe clip 180 for holding or handling the introducer 104.
The RICC 102 can further include a sterile barrier 182 (e.g., a collapsible or pleatable bag, a casing, etc.) configured to maintain sterility of the catheter tube 108 between the catheter hub 110 and the distal coupler 172 prior to insertion of the catheter tube 108 into a blood-vessel lumen of a patient. In at least the ready-to-deploy state of the RICC assembly 100, the sterile barrier 182 is over the catheter tube 108, between the catheter hub 110 about the proximal-end portion of the catheter tube 108 and the distal coupler 172, and coupled to the distal coupler 172. The sterile barrier 182 is configured to split apart when a sterile-barrier tab 184 of the sterile barrier 182 is removed from the catheter-hub clip 178 in which it is tucked and pulled away from the catheter tube 108, thereby providing a no-touch mechanism for removing the sterile barrier 182 from the catheter tube 108. The sterile barrier 182 has sufficient tensile strength to pull the distal coupler 172 off the catheter tube 108 without breaking when the sterile barrier 182 splits down to the distal coupler 172 while being pulled away from the catheter tube 108.
As set forth above,
Methods
A method of the RICC assembly 100 includes a method for inserting the RICC 102 into a blood-vessel lumen of a patient. Such a method includes, in some embodiments, a RICC assembly-obtaining step, a needle tract-establishing step, a first RICC-advancing step, and an introducer-withdrawing step.
The RICC assembly-obtaining step includes obtaining the RICC assembly 100. As set forth above, the RICC assembly 100 includes the RICC 102, the introducer 104 including the syringe 144 coupled to the introducer needle 143, and the coupling system 106 including the distal coupler 172 that couples the RICC 102 and the introducer 104 together by distal-end portions thereof in at least the ready-to-deploy state of the RICC assembly 100.
The method can further include a cannula tip-ensuring step of ensuring the cannula tip 154 extends from the distal end of the RICC 102 before the needle tract-establishing step. As set forth above, the cannula 152 extends through the longitudinal through hole of the distal coupler 172, through the side aperture 116 in the distal-end portion of the catheter tube 108, along the introducing lumen 124 of the catheter tube 108, and out the distal end of the RICC 102.
The needle tract-establishing step includes establishing a needle tract from an area of skin to the blood-vessel lumen of the patient with the cannula 152 of the introducer needle 143 while holding a distal-end portion of the barrel 158 of the syringe 144, for example, together with the syringe clip 180 of the proximal coupler 174 around the distal-end portion of the barrel 158. The needle tract-establishing step can also include ensuring blood flashes back into the needle hub 150 of the introducer needle 143, the side arm 156 of the needle hub 150, or the fluid-pressure indicator 148 extending from the side arm 156 of the needle hub 150.
The method can further include a blood-aspirating step. The blood-aspirating step includes aspirating blood with the syringe 144 before the access guidewire-advancing step set forth below or the introducer-withdrawing step. The blood-aspirating step confirms the cannula tip 154 is disposed in the blood-vessel lumen of the patient.
The method can further include an access guidewire-advancing step of advancing the access guidewire 146 into the blood-vessel lumen beyond a distal end of the cannula 152 (e.g., the cannula tip 154) before the first RICC-advancing step. As set forth above, the access guidewire 146 is disposed in the access-guidewire lumen 164 formed of at least the plunger lumen of the plunger 160 of the syringe 144 and the needle lumen of the introducer needle 143, which facilitates first-stick success by making the access guidewire 146 immediately available before the blood-lumen vessel can be lost due to small inadvertent movements. The access guidewire-advancing step should be performed before the first RICC-advancing step such that the distal-end portion of the catheter tube 108 can be advanced over the access guidewire 146 as well.
The first RICC-advancing step includes advancing the distal-end portion of the catheter tube 108 into the blood-vessel lumen over the cannula 152, the access guidewire 146, or both. As set forth above, the catheter tube 108 includes the first section 118 formed of the first material having the first durometer and the second section 120 formed of the second material having the second durometer less than the first durometer. The first section 118 of the catheter tube 108 is configured with a column strength for advancing the catheter tube 108 into the blood-vessel lumen over the access guidewire 146 or the maneuver guidewire 138 after the maneuver guidewire-advancing step set forth below. For example, the first RICC-advancing step can include advancing the catheter tube 108 into the blood-vessel lumen with a single finger of a hand (e.g., with a flick-type motion of the finger) while holding the barrel 158 of the syringe 144 by the syringe clip 180 between a thumb and another finger or fingers of the same hand. The distal coupler 172 includes the tab 176 configured for advancing the catheter tube 108 into the blood-vessel lumen with the single finger.
The first catheter-advancing step can also include advancing the catheter hub 110 of the RICC 102 from the catheter-hub clip 178 of the proximal coupler 174. After advancing the catheter hub 110 from the catheter-hub clip 178, the one-or-more extension legs 112 of the RICC 102 are advanced within the catheter-hub clip 178 in accordance with the first catheter-advancing step. The RICC 102 is configured to suspend from the coupling system 106 until at least withdrawing the cannula 152 from both the introducing lumen 124 and the longitudinal through hole of the distal coupler 172 such as after the introducer-removing step set forth below.
The method can further include an access guidewire-withdrawing step of withdrawing the access guidewire 146 from the blood-vessel lumen of the patient such as by the stop end of the access guidewire 146. The access guidewire-withdrawing step can be performed after the first catheter-advancing step such as after the distal-end portion of the catheter tube 108 is suitably placed within the blood-vessel lumen over both the cannula 152 and the access guidewire 146.
The introducer-withdrawing step includes withdrawing the cannula 152 from the introducing lumen 124 by way of the side aperture 116 of the catheter tube 108. Like the access guidewire-withdrawing step, the introducer-withdrawing step can be performed after the first catheter-advancing step such as after the distal-end portion of the catheter tube 108 is suitably placed within the blood-vessel lumen over both the cannula 152 and the access guidewire 146.
The method can further include an introducer-removing step of completely removing the introducer 104 from the RICC assembly 100 after the introducer-withdrawing step. The introducer-removing step includes withdrawing the cannula 152 from the longitudinal through hole of the distal coupler 172 while proximally sliding the catheter-hub clip 178 along the one-or-more extension legs 112. Upon withdrawing the cannula 152 from the longitudinal through hole of the distal coupler 172, each extension leg of the one-or-more extension legs 112 can be removed through an opening in the catheter-hub clip 178, which opening is commensurate with or slightly wider in diameter than that of any extension leg.
The method can further include a maneuver guidewire-advancing step of advancing the maneuver guidewire 138 into the blood-vessel lumen by way of, for example, the distal-lumen aperture 132 in the distal end of the RICC 102. As set forth above, the introducing lumen 124 of the catheter tube 108 is coincident with the distal-end portion of the distal lumen 126, particularly the distal-end portion of the distal lumen 126 distal of the side aperture 116. As such, the introducer-removing step of completely removing the introducer 104 from the RICC assembly 100 should be performed before the maneuver guidewire-advancing step to ensure the distal lumen 126, or the introducing lumen 124 thereof, is free of both the cannula 152 and the access guidewire 146.
The method can further include a second RICC-advancing step of advancing the distal-end portion of the catheter tube 108 farther into the blood-vessel lumen over the maneuver guidewire 138 such as to the SVC. The maneuver guidewire 138 provides the second section 120 of the catheter tube 108 columnar strength for the second RICC-advancing step. Concomitantly, the second catheter-advancing step includes sliding the distal coupler 172 proximally towards the catheter hub 110 to uncover the catheter tube 108. As set forth above, the catheter tube 108 is covered by the sterile barrier 182 between the catheter hub 110 about the proximal-end portion of the catheter tube 108 and the distal coupler 172 in at least the ready-to-deploy state of the RICC assembly 100.
The method can further include a sterile barrier-removing step of removing the sterile barrier 182 and a remainder of the coupling system 106 from the RICC 102. The sterile barrier-removing step includes removing the sterile barrier 182 and the distal coupler 172 from the RICC 102 by pulling the sterile-barrier tab 184 of the sterile barrier 182 opposite the distal coupler 172 away from the catheter tube 108 to split the sterile barrier 182 apart along its length, then pulling the distal coupler 172 from the catheter tube 108 by the sterile barrier 182 to which the distal coupler 172 is slidably attached.
The method can further include a maneuver guidewire-withdrawing step of withdrawing the maneuver guidewire 138 from the blood-vessel lumen of the patient, as well as withdrawing the maneuver guidewire 138 from the RICC 102.
While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.
This application claims the benefit of priority to U.S. Patent Application Ser. No. 63/014,555, filed Apr. 23, 2020, which is incorporated by reference in its entirety into this application.
Number | Name | Date | Kind |
---|---|---|---|
1013691 | Shields | Jan 1912 | A |
3225762 | Guttman | Dec 1965 | A |
3382872 | Rubin | May 1968 | A |
3570485 | Reilly | Mar 1971 | A |
3890976 | Bazell et al. | Jun 1975 | A |
4205675 | Vaillancourt | Jun 1980 | A |
4292970 | Hession, Jr. | Oct 1981 | A |
4468224 | Enzmann et al. | Aug 1984 | A |
4525157 | Vaillancourt | Jun 1985 | A |
4581019 | Curelaru et al. | Apr 1986 | A |
4594073 | Stine | Jun 1986 | A |
4702735 | Luther et al. | Oct 1987 | A |
4743265 | Whitehouse et al. | May 1988 | A |
4766908 | Clement | Aug 1988 | A |
4863432 | Kvalo | Sep 1989 | A |
4950252 | Luther et al. | Aug 1990 | A |
4994040 | Cameron et al. | Feb 1991 | A |
5017259 | Kohsai | May 1991 | A |
5040548 | Yock | Aug 1991 | A |
5057073 | Martin | Oct 1991 | A |
5112312 | Luther | May 1992 | A |
5115816 | Lee | May 1992 | A |
5120317 | Luther | Jun 1992 | A |
5158544 | Weinstein | Oct 1992 | A |
5188593 | Martin | Feb 1993 | A |
5195962 | Martin et al. | Mar 1993 | A |
5207650 | Martin | May 1993 | A |
5267958 | Buchbinder et al. | Dec 1993 | A |
5295970 | Clinton et al. | Mar 1994 | A |
5306247 | Pfenninger | Apr 1994 | A |
5322512 | Mohiuddin | Jun 1994 | A |
5328472 | Steinke et al. | Jul 1994 | A |
5350358 | Martin | Sep 1994 | A |
5358495 | Lynn | Oct 1994 | A |
5368567 | Lee | Nov 1994 | A |
5378230 | Mahurkar | Jan 1995 | A |
5380290 | Makower et al. | Jan 1995 | A |
5389087 | Miraki | Feb 1995 | A |
5439449 | Mapes et al. | Aug 1995 | A |
5443457 | Ginn et al. | Aug 1995 | A |
5460185 | Johnson et al. | Oct 1995 | A |
5489271 | Andersen | Feb 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5683370 | Luther et al. | Nov 1997 | A |
5718678 | Fleming, III | Feb 1998 | A |
5772636 | Brimhall et al. | Jun 1998 | A |
5885251 | Luther | Mar 1999 | A |
5919164 | Andersen | Jul 1999 | A |
5921971 | Agro | Jul 1999 | A |
5947940 | Beisel | Sep 1999 | A |
5957893 | Luther et al. | Sep 1999 | A |
5971957 | Luther et al. | Oct 1999 | A |
6159198 | Gardeski et al. | Dec 2000 | A |
6206849 | Martin et al. | Mar 2001 | B1 |
6228062 | Howell et al. | May 2001 | B1 |
6475187 | Gerberding | Nov 2002 | B1 |
6606515 | Windheuser et al. | Aug 2003 | B1 |
6626869 | Bint | Sep 2003 | B1 |
6716228 | Tal | Apr 2004 | B2 |
6726659 | Stocking et al. | Apr 2004 | B1 |
6819951 | Patel et al. | Nov 2004 | B2 |
6821287 | Jang | Nov 2004 | B1 |
6926692 | Katoh et al. | Aug 2005 | B2 |
6962575 | Tal | Nov 2005 | B2 |
6991625 | Gately et al. | Jan 2006 | B1 |
6994693 | Tal | Feb 2006 | B2 |
6999809 | Currier et al. | Feb 2006 | B2 |
7025746 | Tal | Apr 2006 | B2 |
7029467 | Currier et al. | Apr 2006 | B2 |
7037293 | Carrillo et al. | May 2006 | B2 |
7074231 | Jang | Jul 2006 | B2 |
7141050 | Deal et al. | Nov 2006 | B2 |
7144386 | Korkor et al. | Dec 2006 | B2 |
7311697 | Osborne | Dec 2007 | B2 |
7364566 | Elkins et al. | Apr 2008 | B2 |
7377910 | Katoh et al. | May 2008 | B2 |
7390323 | Jang | Jun 2008 | B2 |
D600793 | Bierman et al. | Sep 2009 | S |
D601242 | Bierman et al. | Sep 2009 | S |
D601243 | Bierman et al. | Sep 2009 | S |
7594911 | Powers et al. | Sep 2009 | B2 |
7691093 | Brimhall | Apr 2010 | B2 |
7722567 | Tal | May 2010 | B2 |
D617893 | Bierman et al. | Jun 2010 | S |
D624643 | Bierman et al. | Sep 2010 | S |
7819889 | Healy et al. | Oct 2010 | B2 |
7857788 | Racz | Dec 2010 | B2 |
D630729 | Bierman et al. | Jan 2011 | S |
7909797 | Kennedy, II et al. | Mar 2011 | B2 |
7909811 | Agro et al. | Mar 2011 | B2 |
7922696 | Tal et al. | Apr 2011 | B2 |
7938820 | Webster et al. | May 2011 | B2 |
7967834 | Tal et al. | Jun 2011 | B2 |
7976511 | Fojtik | Jul 2011 | B2 |
7985204 | Katoh et al. | Jul 2011 | B2 |
8073517 | Burchman | Dec 2011 | B1 |
8105286 | Anderson et al. | Jan 2012 | B2 |
8192402 | Anderson et al. | Jun 2012 | B2 |
8202251 | Bierman et al. | Jun 2012 | B2 |
8206356 | Katoh et al. | Jun 2012 | B2 |
8361011 | Mendels | Jan 2013 | B2 |
8372107 | Tupper | Feb 2013 | B2 |
8377006 | Tal et al. | Feb 2013 | B2 |
8454577 | Joergensen et al. | Jun 2013 | B2 |
8585858 | Kronfeld et al. | Nov 2013 | B2 |
8657790 | Tal et al. | Feb 2014 | B2 |
8672888 | Tal | Mar 2014 | B2 |
8696645 | Tal et al. | Apr 2014 | B2 |
8784362 | Boutilette et al. | Jul 2014 | B2 |
8827958 | Bierman et al. | Sep 2014 | B2 |
8876704 | Golden et al. | Nov 2014 | B2 |
8882713 | Call et al. | Nov 2014 | B1 |
8900192 | Anderson et al. | Dec 2014 | B2 |
8900207 | Uretsky | Dec 2014 | B2 |
8915884 | Tal et al. | Dec 2014 | B2 |
8956327 | Bierman et al. | Feb 2015 | B2 |
9023093 | Pal | May 2015 | B2 |
9067023 | Bertocci | Jun 2015 | B2 |
9126012 | McKinnon et al. | Sep 2015 | B2 |
9138252 | Bierman et al. | Sep 2015 | B2 |
9180275 | Helm | Nov 2015 | B2 |
9265920 | Rundquist et al. | Feb 2016 | B2 |
9272121 | Piccagli | Mar 2016 | B2 |
9445734 | Grunwald | Sep 2016 | B2 |
9522254 | Belson | Dec 2016 | B2 |
9554785 | Walters et al. | Jan 2017 | B2 |
9566087 | Bierman et al. | Feb 2017 | B2 |
9675784 | Belson | Jun 2017 | B2 |
9713695 | Bunch et al. | Jul 2017 | B2 |
9764117 | Bierman et al. | Sep 2017 | B2 |
9770573 | Golden et al. | Sep 2017 | B2 |
9814861 | Boutillette et al. | Nov 2017 | B2 |
9820845 | von Lehe et al. | Nov 2017 | B2 |
9861383 | Clark | Jan 2018 | B2 |
9872971 | Blanchard | Jan 2018 | B2 |
9884169 | Bierman et al. | Feb 2018 | B2 |
9889275 | Voss et al. | Feb 2018 | B2 |
9913585 | McCaffrey et al. | Mar 2018 | B2 |
9913962 | Tal et al. | Mar 2018 | B2 |
9981113 | Bierman | May 2018 | B2 |
10010312 | Tegels | Jul 2018 | B2 |
10065020 | Gaur | Sep 2018 | B2 |
10086170 | Chhikara et al. | Oct 2018 | B2 |
10098724 | Adams et al. | Oct 2018 | B2 |
10111683 | Tsamir et al. | Oct 2018 | B2 |
10118020 | Avneri et al. | Nov 2018 | B2 |
10130269 | McCaffrey et al. | Nov 2018 | B2 |
10220184 | Clark | Mar 2019 | B2 |
10220191 | Belson et al. | Mar 2019 | B2 |
10265508 | Baid | Apr 2019 | B2 |
10271873 | Steingisser et al. | Apr 2019 | B2 |
10376675 | Mitchell et al. | Aug 2019 | B2 |
10675440 | Abitabilo et al. | Jun 2020 | B2 |
10806901 | Burkholz et al. | Oct 2020 | B2 |
10926060 | Stern et al. | Feb 2021 | B2 |
11260206 | Stone et al. | Mar 2022 | B2 |
20020040231 | Wysoki | Apr 2002 | A1 |
20020198492 | Miller et al. | Dec 2002 | A1 |
20030036712 | Heh et al. | Feb 2003 | A1 |
20030060863 | Dobak | Mar 2003 | A1 |
20030088212 | Tal | May 2003 | A1 |
20030100849 | Jang | May 2003 | A1 |
20030153874 | Tal | Aug 2003 | A1 |
20030158514 | Tal | Aug 2003 | A1 |
20040015138 | Currier et al. | Jan 2004 | A1 |
20040064086 | Gottlieb et al. | Apr 2004 | A1 |
20040116864 | Boudreaux | Jun 2004 | A1 |
20040116901 | Appling | Jun 2004 | A1 |
20040167478 | Mooney et al. | Aug 2004 | A1 |
20040193093 | Desmond | Sep 2004 | A1 |
20040230178 | Wu | Nov 2004 | A1 |
20050004554 | Osborne | Jan 2005 | A1 |
20050120523 | Schweikert | Jun 2005 | A1 |
20050131343 | Abrams et al. | Jun 2005 | A1 |
20050215956 | Nerney | Sep 2005 | A1 |
20050245882 | Elkins et al. | Nov 2005 | A1 |
20050283221 | Mann et al. | Dec 2005 | A1 |
20060009740 | Higgins et al. | Jan 2006 | A1 |
20060116629 | Tal et al. | Jun 2006 | A1 |
20060129100 | Tal | Jun 2006 | A1 |
20060129130 | Tal et al. | Jun 2006 | A1 |
20070276288 | Khaw | Nov 2007 | A1 |
20080045894 | Perchik et al. | Feb 2008 | A1 |
20080125744 | Treacy | May 2008 | A1 |
20080125748 | Patel | May 2008 | A1 |
20080132850 | Fumiyama et al. | Jun 2008 | A1 |
20080262430 | Anderson et al. | Oct 2008 | A1 |
20080262431 | Anderson et al. | Oct 2008 | A1 |
20080294111 | Tal et al. | Nov 2008 | A1 |
20080312578 | DeFonzo et al. | Dec 2008 | A1 |
20080319387 | Amisar et al. | Dec 2008 | A1 |
20090187147 | Kurth et al. | Jul 2009 | A1 |
20090221961 | Tal et al. | Sep 2009 | A1 |
20090270889 | Tal et al. | Oct 2009 | A1 |
20100030154 | Duffy | Feb 2010 | A1 |
20100256487 | Hawkins et al. | Oct 2010 | A1 |
20100298839 | Castro | Nov 2010 | A1 |
20100305474 | DeMars et al. | Dec 2010 | A1 |
20110004162 | Tal | Jan 2011 | A1 |
20110009827 | Bierman et al. | Jan 2011 | A1 |
20110021994 | Anderson et al. | Jan 2011 | A1 |
20110066142 | Tal et al. | Mar 2011 | A1 |
20110071502 | Asai | Mar 2011 | A1 |
20110144620 | Tal | Jun 2011 | A1 |
20110152836 | Riopelle et al. | Jun 2011 | A1 |
20110202006 | Bierman et al. | Aug 2011 | A1 |
20110251559 | Tal et al. | Oct 2011 | A1 |
20110270192 | Anderson et al. | Nov 2011 | A1 |
20120041371 | Tal et al. | Feb 2012 | A1 |
20120065590 | Bierman et al. | Mar 2012 | A1 |
20120078231 | Hoshinouchi | Mar 2012 | A1 |
20120130411 | Tal et al. | May 2012 | A1 |
20120130415 | Tal et al. | May 2012 | A1 |
20120157854 | Kurrus et al. | Jun 2012 | A1 |
20120215171 | Christiansen | Aug 2012 | A1 |
20120220942 | Hall et al. | Aug 2012 | A1 |
20120226239 | Green | Sep 2012 | A1 |
20120283640 | Anderson et al. | Nov 2012 | A1 |
20120316500 | Bierman et al. | Dec 2012 | A1 |
20130053763 | Makino et al. | Feb 2013 | A1 |
20130053826 | Shevgoor | Feb 2013 | A1 |
20130123704 | Bierman et al. | May 2013 | A1 |
20130158338 | Kelly et al. | Jun 2013 | A1 |
20130188291 | Vardiman | Jul 2013 | A1 |
20130237931 | Tal et al. | Sep 2013 | A1 |
20130306079 | Tracy | Nov 2013 | A1 |
20140025036 | Bierman et al. | Jan 2014 | A1 |
20140081210 | Bierman et al. | Mar 2014 | A1 |
20140094774 | Blanchard | Apr 2014 | A1 |
20140100552 | Gallacher et al. | Apr 2014 | A1 |
20140207052 | Tal et al. | Jul 2014 | A1 |
20140207069 | Bierman et al. | Jul 2014 | A1 |
20140214005 | Belson | Jul 2014 | A1 |
20140257111 | Yamashita et al. | Sep 2014 | A1 |
20140276432 | Bierman et al. | Sep 2014 | A1 |
20140276599 | Cully et al. | Sep 2014 | A1 |
20150080939 | Adams et al. | Mar 2015 | A1 |
20150094653 | Pacheco et al. | Apr 2015 | A1 |
20150112310 | Call et al. | Apr 2015 | A1 |
20150126930 | Bierman et al. | May 2015 | A1 |
20150148595 | Bagwell et al. | May 2015 | A1 |
20150190168 | Bierman et al. | Jul 2015 | A1 |
20150196210 | McCaffrey et al. | Jul 2015 | A1 |
20150224287 | Bian et al. | Aug 2015 | A1 |
20150283357 | Lampropoulos et al. | Oct 2015 | A1 |
20150297868 | Tal et al. | Oct 2015 | A1 |
20150320969 | Haslinger et al. | Nov 2015 | A1 |
20150320977 | Vitullo et al. | Nov 2015 | A1 |
20150351793 | Bierman et al. | Dec 2015 | A1 |
20150359549 | Lenker et al. | Dec 2015 | A1 |
20150359998 | Carmel et al. | Dec 2015 | A1 |
20160082223 | Barnell | Mar 2016 | A1 |
20160114124 | Tal | Apr 2016 | A1 |
20160158523 | Helm | Jun 2016 | A1 |
20160220786 | Mitchell | Aug 2016 | A1 |
20160325073 | Davies et al. | Nov 2016 | A1 |
20160338728 | Tal | Nov 2016 | A1 |
20160346503 | Jackson et al. | Dec 2016 | A1 |
20170035990 | Swift | Feb 2017 | A1 |
20170072165 | Lim et al. | Mar 2017 | A1 |
20170120000 | Osypka et al. | May 2017 | A1 |
20170120014 | Harding et al. | May 2017 | A1 |
20170120034 | Kaczorowski | May 2017 | A1 |
20170128700 | Roche Rebollo | May 2017 | A1 |
20170156987 | Babbs et al. | Jun 2017 | A1 |
20170172653 | Urbanski et al. | Jun 2017 | A1 |
20170239443 | Abitabilo et al. | Aug 2017 | A1 |
20170259043 | Chan et al. | Sep 2017 | A1 |
20170273713 | Shah et al. | Sep 2017 | A1 |
20170326339 | Bailey et al. | Nov 2017 | A1 |
20170361070 | Hivert | Dec 2017 | A1 |
20170368255 | Provost et al. | Dec 2017 | A1 |
20180001062 | O'Carrol et al. | Jan 2018 | A1 |
20180021545 | Mitchell et al. | Jan 2018 | A1 |
20180116690 | Sarabia et al. | May 2018 | A1 |
20180117284 | Appling et al. | May 2018 | A1 |
20180133438 | Hulvershorn et al. | May 2018 | A1 |
20180154062 | DeFonzo et al. | Jun 2018 | A1 |
20180154112 | Chan et al. | Jun 2018 | A1 |
20180214674 | Ebnet et al. | Aug 2018 | A1 |
20180296799 | Horst et al. | Oct 2018 | A1 |
20180296804 | Bierman | Oct 2018 | A1 |
20180310955 | Lindekugel et al. | Nov 2018 | A1 |
20190015646 | Matlock et al. | Jan 2019 | A1 |
20190060616 | Solomon | Feb 2019 | A1 |
20190076167 | Fantuzzi et al. | Mar 2019 | A1 |
20190134349 | Cohn et al. | May 2019 | A1 |
20190192824 | Cordeiro et al. | Jun 2019 | A1 |
20190201665 | Turpin | Jul 2019 | A1 |
20190209812 | Burkholz et al. | Jul 2019 | A1 |
20190255294 | Mitchell et al. | Aug 2019 | A1 |
20190255298 | Mitchell et al. | Aug 2019 | A1 |
20190275303 | Tran et al. | Sep 2019 | A1 |
20190276268 | Akingba | Sep 2019 | A1 |
20190321590 | Burkholz et al. | Oct 2019 | A1 |
20200001051 | Huang et al. | Jan 2020 | A1 |
20200016374 | Burkholz et al. | Jan 2020 | A1 |
20200046948 | Burkholz et al. | Feb 2020 | A1 |
20200100716 | Devgon et al. | Apr 2020 | A1 |
20200129732 | Vogt et al. | Apr 2020 | A1 |
20200147349 | Holt | May 2020 | A1 |
20200197682 | Franklin et al. | Jun 2020 | A1 |
20200197684 | Wax | Jun 2020 | A1 |
20200237278 | Asbaghi | Jul 2020 | A1 |
20200359995 | Walsh et al. | Nov 2020 | A1 |
20210030944 | Cushen et al. | Feb 2021 | A1 |
20210069471 | Howell | Mar 2021 | A1 |
20210085927 | Howell | Mar 2021 | A1 |
20210100985 | Akcay et al. | Apr 2021 | A1 |
20210113809 | Howell | Apr 2021 | A1 |
20210113810 | Howell | Apr 2021 | A1 |
20210113816 | DiCianni | Apr 2021 | A1 |
20210121661 | Howell | Apr 2021 | A1 |
20210121667 | Howell | Apr 2021 | A1 |
20210228842 | Scherich et al. | Jul 2021 | A1 |
20210228843 | Howell et al. | Jul 2021 | A1 |
20210290898 | Burkholz | Sep 2021 | A1 |
20210290901 | Burkholz et al. | Sep 2021 | A1 |
20210290913 | Horst et al. | Sep 2021 | A1 |
20210322729 | Howell | Oct 2021 | A1 |
20210330942 | Howell | Oct 2021 | A1 |
20210361915 | Howell et al. | Nov 2021 | A1 |
20210402149 | Howell | Dec 2021 | A1 |
20210402153 | Howell et al. | Dec 2021 | A1 |
20220001138 | Howell | Jan 2022 | A1 |
20220032013 | Howell et al. | Feb 2022 | A1 |
20220032014 | Howell et al. | Feb 2022 | A1 |
20220062528 | Thornley et al. | Mar 2022 | A1 |
20220126064 | Tobin et al. | Apr 2022 | A1 |
20220193376 | Spataro et al. | Jun 2022 | A1 |
20220193377 | Haymond et al. | Jun 2022 | A1 |
20220193378 | Spataro et al. | Jun 2022 | A1 |
20220323723 | Spataro et al. | Oct 2022 | A1 |
20220331563 | Papadia | Oct 2022 | A1 |
20230042898 | Howell et al. | Feb 2023 | A1 |
20230096377 | West et al. | Mar 2023 | A1 |
20230096740 | Bechstein et al. | Mar 2023 | A1 |
20230099654 | Blanchard et al. | Mar 2023 | A1 |
20230100482 | Howell | Mar 2023 | A1 |
20230101455 | Howell et al. | Mar 2023 | A1 |
20230102231 | Bechstein et al. | Mar 2023 | A1 |
20230233814 | Howell et al. | Jul 2023 | A1 |
Number | Date | Country |
---|---|---|
202012006191 | Jul 2012 | DE |
0653220 | May 1995 | EP |
0730880 | Sep 1996 | EP |
2061385 | May 2009 | EP |
1458437 | Mar 2010 | EP |
2248549 | Nov 2010 | EP |
2319576 | May 2011 | EP |
2366422 | Sep 2011 | EP |
2486880 | Aug 2012 | EP |
2486881 | Aug 2012 | EP |
2486951 | Aug 2012 | EP |
2512576 | Oct 2012 | EP |
2152348 | Feb 2015 | EP |
3473291 | Apr 2019 | EP |
3093038 | May 2019 | EP |
2260897 | Sep 2019 | EP |
3693051 | Aug 2020 | EP |
1273547 | May 1972 | GB |
2004248987 | Sep 2004 | JP |
2008054859 | Mar 2008 | JP |
9421315 | Sep 1994 | WO |
9532009 | Nov 1995 | WO |
9844979 | Oct 1998 | WO |
9853871 | Dec 1998 | WO |
9912600 | Mar 1999 | WO |
9926681 | Jun 1999 | WO |
0006221 | Feb 2000 | WO |
0054830 | Sep 2000 | WO |
2003008020 | Jan 2003 | WO |
2003057272 | Jul 2003 | WO |
03068073 | Aug 2003 | WO |
2003066125 | Aug 2003 | WO |
2005096778 | Oct 2005 | WO |
2006055288 | May 2006 | WO |
2006055780 | May 2006 | WO |
2007046850 | Apr 2007 | WO |
2008033983 | Mar 2008 | WO |
2008092029 | Jul 2008 | WO |
2008131300 | Oct 2008 | WO |
2008131289 | Oct 2008 | WO |
2009114833 | Sep 2009 | WO |
2009114837 | Sep 2009 | WO |
2010048449 | Apr 2010 | WO |
2010056906 | May 2010 | WO |
2010083467 | Jul 2010 | WO |
2010132608 | Nov 2010 | WO |
2011081859 | Jul 2011 | WO |
2011097639 | Aug 2011 | WO |
2011109792 | Sep 2011 | WO |
2011146764 | Nov 2011 | WO |
2012068162 | May 2012 | WO |
2012068166 | May 2012 | WO |
2012135761 | Oct 2012 | WO |
2012154277 | Nov 2012 | WO |
2012162677 | Nov 2012 | WO |
2013026045 | Feb 2013 | WO |
2013138519 | Sep 2013 | WO |
2014006403 | Jan 2014 | WO |
2014100392 | Jun 2014 | WO |
2014113257 | Jul 2014 | WO |
2014152005 | Sep 2014 | WO |
2014197614 | Dec 2014 | WO |
2015057766 | Apr 2015 | WO |
2015077560 | May 2015 | WO |
2015168655 | Nov 2015 | WO |
2016110824 | Jul 2016 | WO |
2016123278 | Aug 2016 | WO |
2016139590 | Sep 2016 | WO |
2016139597 | Sep 2016 | WO |
2016178974 | Nov 2016 | WO |
2016187063 | Nov 2016 | WO |
2016176065 | Nov 2016 | WO |
2018089275 | May 2018 | WO |
2018089285 | May 2018 | WO |
2018089385 | May 2018 | WO |
2018191547 | Oct 2018 | WO |
2018213148 | Nov 2018 | WO |
2018218236 | Nov 2018 | WO |
2019050576 | Mar 2019 | WO |
2019146026 | Aug 2019 | WO |
2019199734 | Oct 2019 | WO |
2020014149 | Jan 2020 | WO |
2020069395 | Apr 2020 | WO |
2020109448 | Jun 2020 | WO |
2020113123 | Jun 2020 | WO |
2021050302 | Mar 2021 | WO |
2021077103 | Apr 2021 | WO |
2021062023 | Apr 2021 | WO |
2021081205 | Apr 2021 | WO |
2021086793 | May 2021 | WO |
2021236950 | Nov 2021 | WO |
2022031618 | Feb 2022 | WO |
2022094141 | May 2022 | WO |
2022133297 | Jun 2022 | WO |
2022-140406 | Jun 2022 | WO |
2022140429 | Jun 2022 | WO |
2022217098 | Oct 2022 | WO |
2023014994 | Feb 2023 | WO |
2023049498 | Mar 2023 | WO |
2023049505 | Mar 2023 | WO |
2023049511 | Mar 2023 | WO |
2023049519 | Mar 2023 | WO |
2023049522 | Mar 2023 | WO |
Entry |
---|
PCT/US2020/048583 filed Aug. 28, 2020 International Search Report and Written Opinion dated Nov. 13, 2020. |
PCT/US2020/052536 filed Sep. 24, 2020 International Search Report and Written Opinion dated Dec. 4, 2020. |
PCT/US2020/056364 filed Oct. 19, 2020 International Search Report and Written Opinion dated Jan. 19, 2021. |
PCT/US2020/056864 filed Oct. 22, 2020 International Search Report and Written Opinion dated Jan. 14, 2021. |
PCT/US2020/057202 filed Oct. 23, 2020 International Search Report and Written Opinion dated Jan. 21, 2021. |
PCT/US2020/057397 filed Oct. 26, 2020 International Search Report and Written Opinion dated Mar. 10, 2021. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Final Office Action dated May 30, 2018. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Non-Final Office Action dated Jan. 25, 2019. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Non-Final Office Action dated Nov. 2, 2017. |
U.S. Appl. No. 15/008,628, filed Jan. 28, 2016 Notice of Allowance dated May 15, 2019. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Non-Final Office Action dated May 11, 2021. |
PCT/US2022/039614 filed Aug. 5, 2022 International Search Report and Written Opinion dated Dec. 22, 2022. |
PCT/US2022/044848 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 3, 2023. |
PCT/US2022/044879 filed Sep. 27, 2022 International Search Report and Written Opinion dated Mar. 3, 2023. |
PCT/US2022/044901 filed Sep. 27, 2022 International Search Report and Written Opinion dated Mar. 3, 2023. |
PCT/US2022/044918 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 21, 2023. |
PCT/US2022/044923 filed Sep. 27, 2022 International Search Report and Written Opinion dated Feb. 15, 2023. |
U.S. Appl. No. 17/326,017, filed May 20, 2021 Non-Final Office Action dated Jan. 26, 2023. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Mar. 2, 2023. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Restriction Requirement dated Mar. 30, 2023. |
PCT/US2021/039084 filed Jun. 25, 2021 International Search Report and Written Opinion dated Jan. 10, 2022. |
PCT/US2021/039843 filed Jun. 30, 2021 International Search Report and Written Opinion dated Nov. 11, 2021. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Final Office Action dated Jan. 25, 2022. |
U.S. Appl. No. 17/006,553, filed Aug. 28, 2020 Non-Final Office Action dated Mar. 16, 2022. |
U.S. Appl. No. 17/077,728, filed Oct. 22, 2020 Non-Final Office Action dated Feb. 9, 2022. |
PCT/US2021/028018 filed Apr. 19, 2021 International Preliminary Report on Patentability dated Jun. 3, 2022. |
PCT/US2021/064174 filed Dec. 17, 2021 International Search Report and Written Opinion dated May 18, 2022. |
PCT/US2021/064671 filed Dec. 21, 2021 International Search Report and Written Opinion dated May 27, 2022. |
PCT/US2022/024085 filed Apr. 8, 2022 International Search Report and Wirtten Opinion dated Sep. 12, 2022. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Examiner's Answer dated Oct. 31, 2022. |
U.S. Appl. No. 17/031,478, filed Sep. 24, 2020 Notice of Allowance dated Sep. 16, 2022. |
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Non-Final Office Action dated Oct. 25, 2022. |
PCT/US2021/028683 filed Apr. 22, 2021 International Search Report and Written Opinion dated Sep. 16, 2021. |
PCT/US2021/029183 filed Apr. 26, 2021 International Search Report and Written Opinion dated Sep. 24, 2021. |
PCT/US2021/033443 filed May 20, 2021 International Search Report and Written Opinion dated Sep. 23, 2021. |
PCT/US2021/044029 filed Jul. 30, 2021 International Search Report and Written Opinion dated Dec. 9, 2021. |
PCT/US2021/057135 filed Oct. 28, 2021 International Preliminary Report on Patentability dated May 2, 2023. |
PCT/US2021/057135 filed Oct. 28, 2021 International Search Report and Written Opinion dated Mar. 11, 2022. |
PCT/US2023/011173 filed Jan. 19, 2023 International Search Report and Written Opinion dated May 22, 2023. |
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Notice of Allowance dated Apr. 24, 2023. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Non-Final Office Action dated Jun. 8, 2023. |
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Restriction Requirement dated Jun. 7, 2023. |
PCT/US2021/044223 filed Aug. 2, 2021 International Search Report and Written Opinion dated Dec. 21, 2021. |
PCT/US2021/048275 filed Aug. 30, 2021 International Search Report and Written Opinion dated Jan. 4, 2022. |
PCT/US2021/064642 filed Dec. 21, 2021 International Search Report and Written Opinion dated May 11, 2022. |
U.S. Appl. No. 17/031,478, filed Sep. 24, 2020 Non-Final Office Action dated May 11, 2022. |
U.S. Appl. No. 17/156,252, filed Jan. 22, 2021 Notice of Allowance dated Aug. 9, 2023. |
U.S. Appl. No. 17/326,017, filed May 20, 2021 Notice of Allowance dated Jul. 3, 2023. |
U.S. Appl. No. 17/358,504, filed Jun. 25, 2021 Non-Final Office Action dated Oct. 4, 2023. |
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Restriction Requirement dated Jul. 20, 2023. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Final Office Action dated Jul. 27, 2023. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Non-Final Office Action dated Jul. 17, 2023. |
U.S. Appl. No. 17/513,789, filed Oct. 28, 2021 Restriction Requirement dated Oct. 3, 2023. |
PCT/US2021/014700 filed Jan. 22, 2021 International Search Report and Written Opinion dated Jun. 29, 2021. |
PCT/US2021/028018 filed Apr. 19, 2021 International Search Report and Written Opinion dated Sep. 13, 2021. |
U.S. Appl. No. 16/398,020, filed Apr. 29, 2019 Board Decision dated Oct. 30, 2023. |
U.S. Appl. No. 17/240,591, filed Apr. 26, 2021 Final Office Action dated Dec. 6, 2023. |
U.S. Appl. No. 17/360,694, filed Jun. 28, 2021 Non-Final Office Action dated Oct. 13, 2023. |
U.S. Appl. No. 17/390,682, filed Jul. 30, 2021 Non-Final Office Action dated Dec. 1, 2023. |
U.S. Appl. No. 17/392,061, filed Aug. 2, 2021 Final Office Action dated Nov. 21, 2023. |
U.S. Appl. No. 17/557,924, filed Dec. 21, 2021 Non-Final Office Action dated Nov. 3, 2023. |
Number | Date | Country | |
---|---|---|---|
20210330941 A1 | Oct 2021 | US |
Number | Date | Country | |
---|---|---|---|
63014555 | Apr 2020 | US |